Overview
Parkinson’s infection (PD) is a persistent problem described by the breaking down and demise of imperative nerve cells in the mind, and can be portrayed by quake, dementia, and melancholy. Parkinson’s infection movement prompts uncontrolled body development of the patient. There is no fix by and by for Parkinson’s illness just medicines choices such as drug and medical procedure to deal with the indications are accessible. Parkinson’s sickness basically influences individuals more than 50 and the danger increments with expanding age. Parkinson’s sickness therapy is utilized to control indications like uncontrolled development, unsteadiness of hands, and some others. The restorative methodologies like levodopa in mix with carbidopa is considered as a viable treatment over indications of Parkinson’s infection. The careful treatment choice is accessible yet it is just successful for patients who are recently reacted to levodopa treatment. The innovative work in the field of Parkinson’s sickness restorative will help in the therapy of Parkinson’s infection.
Get PDF Sample Copy (Including Full TOC, List of Tables & Figures, Chart) @
https://www.coherentmarketinsights.com/insight/request-sample/494
The Parkinson’s Disease Therapeutics industry report further exhibits a pattern of analyzing previous data sources gathered from reliable sources and sets a precedent growth trajectory for the Parkinson’s Disease Therapeutics market. The report also focuses on a comprehensive market revenue streams along with growth patterns, Local reforms, COVID Impact analysis with focused approach on market trends, and the overall growth of the market.
Moreover, the Parkinson’s Disease Therapeutics report describes the market division based on various parameters and attributes that are based on geographical distribution, product types, applications, etc. The market segmentation clarifies further regional distribution for the Parkinson’s Disease Therapeutics market, business trends, potential revenue sources, and upcoming market opportunities.
Drivers
Expansion in predominance of Parkinson’s illness across the world is driving the global Parkinson’s disease therapeutic market. As indicated by Parkinson’s illness establishment, in excess of 10 million individuals universally are living with Parkinson’s infection and 60,000 Americans are determined to have Parkinson’s sickness every year. The rising pervasiveness of Parkinson’s illness across the world is one of the central point which is driving the global Parkinson’s disease therapeutic market. Rising male patients, is additionally the central point inferable from the global Parkinson’s disease therapeutic market, on the grounds that as referenced in the information of Parkinson’s illness establishment, odds of getting Parkinson’s infection is one and half times more in men than women. The increment in number of geriatric populace, innovative headways, and blend treatments for delay activity of nonstop dopaminergic incitement drugs, quality treatment, and neural transplantation are some different causes which are probably going to drive the global Parkinson’s disease therapeutic market.
Restraints
Anyway a few limitations like expiry of licenses for a long time can cause a hindrance in the growth of the global Parkinson’s disease therapeutic market.
Opportunities
The headways in clinical gadgets fragment for Parkinson’s infection treatment is anticipated to help the development in the global Parkinson’s disease therapeutic market.
Request PDF Brochure with Latest Insights @
https://www.coherentmarketinsights.com/insight/request-pdf/494
Regional Analysis
New headways in the treatment of Parkinson’s illness has assisted with helping the development in North America for Parkinson’s infection restorative market.
Higher incidences of Parkinson’s illness and acceptable repayment strategies are some of elements which permits the North America to rule in the global Parkinson’s disease therapeutic market. Over 40 medical facilities are developed for the treatment of Parkinson’s infection and many have acquired the most optimized plan of attack assignment from U.S. Food and Drug Administration (FDA) in North America. North America is projected to hold the biggest offer in the global Parkinson’s disease therapeutic market as a result of expansion in interests in innovative work for Parkinson’s illness.
New item advancement is the key system took on by significant industry player in global Parkinson’s disease therapeutic market during the forecast period.
A large number of the vital participants associated with the counter Parkinson’s illness medicine and a portion of the biopharmaceuticals research organizations in the U.S. are presently in the improvement of new prescriptions for treatment of Parkinson’s illness. The leading brands such as Biogen, Novartis AG, Pfizer, and Ceregene are projected to dispatch new medications for Parkinson’s infection treatment later on.
Competitive Landscape
Major companies contributing to the global Parkinson’s disease therapeutic market include GlaxoSmithKline Plc., Novartis AG, Teva Pharmaceutical Industries Ltd., Salix Pharmaceuticals, Impax Labs, Boehringer Ingelheim, Orion Corporation, and Mylan N.V.
Detailed Segmentation:
Global Parkinson’s Disease Therapeutic Market, By Drug Class
-
- Levodopa
- Dopamine agonists
- MAO-B inhibitors
- Anticholinergics
- Others
Global Parkinson’s Disease Therapeutic Market, By Route of Administration
-
- Oral
- Injectable
- Nasal
- Transdermal
- Others
Global Parkinson’s Disease Therapeutic Market, By Distribution Channel
-
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
𝐂𝐡𝐫𝐢𝐬𝐭𝐦𝐚𝐬 𝐒𝐚𝐥𝐞 𝐈𝐬 𝐋𝐢𝐯𝐞!
𝐁𝐮𝐲 𝐍𝐨𝐰 𝐓𝐨 𝐀𝐯𝐚𝐢𝐥 𝐃𝐢𝐬𝐜𝐨𝐮𝐧𝐭 𝐅𝐫𝐨𝐦 𝟐𝟓-𝟑𝟎% 𝐭𝐢𝐥𝐥 𝟑𝟏-𝐃𝐞𝐜-𝟐𝟎𝟐𝟏
Buy This Complete Business Report @ https://www.coherentmarketinsights.com/insight/buy-now/494
Table of Content
- Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
- Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Drug Class
- Market Snapshot, By Route of Administration
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
- Report Description
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Opportunity
- Impact Analysis
- Pipeline Analysis
- Regulatory Scenario
- Reimbursement Scenario
- Recent Product Approvals/ launches
- Mergers, Acquisitions and Collaboration Scenario
- Market Trends
- Epidemiology
- PEST Analysis
- Market Dynamics
- Global Parkinson’s Disease Therapeutic Market – Impact of Coronavirus (COVID-19) Pandemic
- COVID-19 Epidemiology
- Overall Impact on Healthcare Sector
- COVID-19 Impact on Parkinson’s Disease Drug Class
- Government Measures to Combat COVID-19
- Global Parkinson’s Disease Therapeutic Market, By Drug Class, 2017 – 2028, (US$ Mn)
- Introduction
- Market Share Analysis, 2021 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 – 2028
- Segment Trends
- Levodopa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Dopamine agonists
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- MAO-B inhibitors
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Anticholinergics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Introduction
- Global Parkinson’s Disease Therapeutic Market, By Route of Administration, 2017 – 2028, (US$ Mn)
- Introduction
- Market Share Analysis, 2021 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 – 2028
- Segment Trends
- Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Injectable
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Nasal
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Transdermal
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Introduction
- Global Parkinson’s Disease Therapeutic Market, By Distribution Channel, 2017 – 2028, (US$ Mn)
- Introduction
- Market Share Analysis, 2021 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 – 2028
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Introduction
- Global Parkinson’s Disease Therapeutic Market, By Region, 2017 – 2028, (US$ Mn)
- Introduction
- Market Share Analysis, By Region, 2021 and 2028 (%)
- Y-o-Y Growth Analysis, For Regions, 2017–2028
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 – 2028, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017 – 2028, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 – 2028, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Countries, 2017 – 2028, (US$ Mn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 – 2028, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017 – 2028, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 – 2028, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Countries, 2017 – 2028, (US$ Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 – 2028, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017 – 2028, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 – 2028, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Countries, 2017 – 2028, (US$ Mn)
- U.K.
- Germany
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 – 2028, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017 – 2028, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 – 2028, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Countries, 2017 – 2028, (US$ Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 – 2028, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration 2017 – 2028, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 – 2028, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Countries, 2017 – 2028, (US$ Mn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 – 2028, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017 – 2028, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 – 2028, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Countries/Region, 2017 – 2028, (US$ Mn)
- North Africa
- Central Africa
- South Africa
- Introduction
- Competitive Landscape
- Heat Map Analysis
- Market Share Analysis
- Merck & Co., Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Novartis AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- AbbVie Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- GlaxoSmithKline PLC
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Teva Pharmaceutical Industries Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Zydus Cadila
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Reddy’s Laboratories
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Sun Pharmaceutical Industries Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Cipla Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Boehringer Ingelheim International GmbH
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Merck & Co., Inc.
- Analyst Views
- Section
- Research Methodology
- About us
About Us:
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837